Maxcyte (MXCT) Amortizatization of Intangibles (2020 - 2026)
Maxcyte (MXCT) reported Amortizatization of Intangibles of $437000.0 for Q1 2026, up 141.44% year-over-year from $181000.0 in Q1 2025, and up 130.84% quarter-over-quarter from -$1.4 million in Q4 2025.
Maxcyte (MXCT) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has 7 years of Amortizatization of Intangibles data on file, last reported at $437000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $437000.0, up 141.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (down 83.22% YoY), and the FY2025 annual result was $802000.0, down 87.15% from the prior year.
- Amortizatization of Intangibles improved to $437000.0 in Q1 2026 per MXCT's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $5.9 million in Q4 2024 and troughed at -$3.3 million in Q3 2024.
- A 5-year average of $1.0 million and a median of $584000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2022 and 2024: Amortizatization of Intangibles jumped 4798.05% in 2022, then sank 323.48% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $1.5 million in 2022, then jumped by 32.37% to $2.0 million in 2023, then soared by 194.89% to $5.9 million in 2024, then tumbled by 124.06% to -$1.4 million in 2025, then jumped by 130.84% to $437000.0 in 2026.
- Business Quant data shows MXCT's Amortizatization of Intangibles at $437000.0 in Q1 2026, -$1.4 million in Q4 2025, and $584000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 422.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 180.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 6.50 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 75.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Maxcyte | 120.23 Mn | 120.23 Mn | 8.08 Mn | 437,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 437,000.00 |
| Mar 31, 2026 | 437,000.00 |
| Dec 31, 2025 | -1.42 Mn |
| Dec 31, 2025 | -1.42 Mn |
| Sep 30, 2025 | 584,000.00 |
| Sep 30, 2025 | 584,000.00 |
| Jun 30, 2025 | 1.45 Mn |
| Jun 30, 2025 | 1.45 Mn |
| Mar 31, 2025 | 181,000.00 |
| Mar 31, 2025 | 181,000.00 |
| Dec 31, 2024 | 5.89 Mn |
| Dec 31, 2024 | 5.89 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Jun 30, 2024 | 3.55 Mn |
| Jun 30, 2024 | 3.55 Mn |
| Mar 31, 2024 | 116,000.00 |
| Mar 31, 2024 | 116,000.00 |
| Dec 31, 2023 | 2.00 Mn |
| Dec 31, 2023 | 2.00 Mn |